Cytosolic lipid droplets (LDs) are dynamic, specialized organelles found within the cytoplasm of eukaryotic cells. Unlike most cellular organelles, which are enclosed by a standard lipid bilayer, lipid droplets possess a unique structural architecture tailored specifically for the storage and regulation of energy. Once viewed as static, inert blobs of fat, lipid droplets are now recognized in modern cell biology as highly active hubs for lipid metabolism, cellular signaling, and metabolic homeostasis.
Figure 1: A detailed AI-generated illustration of a liver cell, also known as a hepatocyte, which is the main cell type in the liver (Source: easy-peasy ai).
Cytosolic lipid droplets have a unique structural architecture that is fundamentally different from any other organelle in the cell.
(i) The hydrophobic center of the droplet is devoid of water and is packed with neutral lipids, primarily triacylglycerols (TAGs) and cholesteryl esters (CEs).
(ii) Lipid droplets are surrounded by a single monolayer of phospholipids with the polar headgroups facing the aqueous cytosol, while the hydrophobic fatty acid tails point inward to interact with the neutral lipid core.
(iii) Embedded directly within or localized to this monolayer are specific targeting proteins, such as the Perilipin family, PLIN1–5, and metabolic enzymes like adipose triglyceride lipase (ATGL) and diacylglycerol O-acyltransferase 2 (DGAT2) that regulate lipid synthesis and breakdown.
Figure 2: Lipolysis in lipid droplets. In basal condition, lipolysis of TAG and DAG occurs at low levels thanks to Perilipin A, whereas in simulated condition, phosphorylated Perilipin A allows maximal lipolysis of triacylglycerol (TAG) and diacylglycerol (DAG). (Source: Wiki commons)
Lipid droplets originate directly from the Endoplasmic Reticulum (ER) through a step-by-step budding process: Enzymes within the ER membrane synthesize neutral lipids, including triacylglycerol (TAG) and cholesteryl ester (CE). As these hydrophobic neutral lipids accumulate, they cannot remain solubilized within the ER bilayer. They begin to aggregate and phase-separate, forming a "lens" between the two leaflets of the ER membrane. The lens grows larger, causing the cytoplasmic leaflet of the ER membrane to bulge outward. Specialized protein complexes, such as seipin, help manage this tension, ultimately allowing the nascent droplet to pinch off into the cytosol as an independent, monolayer-bound organelle.
A unique biophysical mechanism drives the targeting of cytosolic proteins to lipid droplets. Unlike typical membrane-bound organelles enclosed by a phospholipid bilayer, LDs feature a hydrophobic core of neutral lipids, primarily triacylglycerols and cholesteryl esters, surrounded by a single phospholipid monolayer.
The majority of LD-associated proteins migrate directly from the cytosol to the monolayer of lipid droplets via amphipathic helices (AHs). The mechanisms and molecular determinants governing this specific targeting rely on a fine balance between helix structure, membrane topology, and surface lipid energetics.
Lipid droplets serve several vital physiological roles beyond acting as a simple cellular pantry. When nutrient levels are high, excess fatty acids are converted into neutral lipids and safely sequestered within LDs via lipogenesis. When the human body requires energy, for example, during fasting or exercise, intracellular lipases are recruited to the LD surface to break down TAGs into free fatty acids via lipolysis, which are then sent to the mitochondria for ATP production via oxidation.
Inside a cell, free, unesterified fatty acids act like detergents; in high concentrations, they disrupt membranes, cause oxidative stress, and trigger apoptosis. LDs safely convert excess fatty acids into neutral lipids to protect the cell from lipotoxicity.
Further, LDs act as a dynamic reservoir not just for fuel, but for building blocks, storing sterols and phospholipids that can be rapidly mobilized to build or repair membranes during cell growth, division, or organelle expansion. However, lipid droplets rarely float completely isolated in the cytosol. They form physical membrane contact sites with other organelles, such as the ER, mitochondria, peroxisomes, and lysosomes. These contact sites allow for the direct, non-vesicular transfer of lipids and signaling molecules between these compartments.
Misregulation of cytosolic lipid droplets results in several major metabolic diseases, including obesity and type 2 diabetes, in which the overloading of adipose and non-adipose tissues with massive lipid droplets leads to chronic inflammation and insulin resistance. Abnormal accumulation of LDs within hepatocytes compromises liver function, leading to hepatic steatosis or fatty liver disease. When macrophages ingest excess cholesterol and store it in massive intracellular lipid droplets until they transform into "foam cells," the resulting plaque buildup in arterial walls results in atherosclerosis.
A study by Rowe et al. in 2016 defined a unique 11-mer repeat architecture of Perilipins, explaining how its altered helical pitch permits optimal extended binding across a single-monolayer interface.
Many LD-coating proteins, notably the Perilipin family (PLIN1, PLIN2, PLIN3), utilize a highly conserved 11-mer amino acid repeat motif; other structural proteins like apolipoproteins utilize 22-mer repeats that form standard amphipathic helices (3.6 residues per turn). The 11-mer repeat creates a slightly altered helical pitch, with approximately 3.67 residues per turn, requiring 3 turns to span 11 residues and slightly shifting the orientation of the hydrophobic face. This structural adaptation allows the helix to lie flat and extended across the curved, shallow polar-apolar interface of a monolayer without penetrating deeply and disrupting the organelle's structural integrity.
Perilipins are proteins that coat and protect lipid droplets in fat storage cells. Perilipins act as dynamic gatekeepers that, under normal conditions, prevent fat breakdown, but when the human body needs energy, hormones activate them, allowing lipases to break down stored fat for fuel.
Krahmer et al. (2013) reviewed the clinical relevance of lipid droplets, detailing the pathophysiology of lipotoxicity, insulin resistance, hepatic steatosis, and the formation of macrophage foam cells in atherosclerosis.
Walter et al. (2017) published a comprehensive overview mapping out the step-by-step molecular biogenesis of lipid droplets from the endoplasmic reticulum (ER), highlighting neutral lipid phase separation, lens formation, and seipin-mediated budding.
A study by Prévost et al. (2018) established a model for how bulky hydrophobic residues sense and fit into persistent lipid packing defects on the lipid droplet monolayer, acting as a filter against standard bilayers. This study utilized peptides conjugated to a fluorophore (Alexa Fluor 488) to visualize the binding of amphipathic helices to cellular lipid droplets.
Giménez-Andrés et al. (2018) reviewed the structural biology of lipid droplets by comparing different classes of amphipathic helices, contrasting lipid droplet-targeting domains with those that sense bilayer curvature (ALPS motifs) or charge.
Olzmann & Carvalho (2019) reviewed the dynamics and functions of lipid droplets throughout their lifecycle, their proteome, and their essential roles in energy buffering, membrane contact site management, and the prevention of lipotoxicity.
Chorlay & Thiam in 2020 reported that the underlying neutral lipid core and changes in surface tension dictate the binding affinity and stabilization of cytosolic amphipathic helices.
References
Chorlay A, Thiam AR. Neutral lipids regulate amphipathic helix affinity for model lipid droplets. J Cell Biol. 2020 Apr 6;219(4):e201907099. [PMC]
Giménez-Andrés M, Čopič A, Antonny B. The Many Faces of Amphipathic Helices. Biomolecules. 2018 Jul 5;8(3):45. [PMC]
Krahmer N, Farese RV Jr, Walther TC. Balancing the fat: lipid droplets and human disease. EMBO Mol Med. 2013 Jul;5(7):973-83. [PMC]
Olzmann JA, Carvalho P. Dynamics and functions of lipid droplets. Nat Rev Mol Cell Biol. 2019 Mar;20(3):137-155. [PMC]
Perilipin
Prévost C, Sharp ME, Kory N, Lin Q, Voth GA, Farese RV Jr, Walther TC. Mechanism and Determinants of Amphipathic Helix-Containing Protein Targeting to Lipid Droplets. Dev Cell. 2018 Jan 8;44(1):73-86.e4. [PMC]
Rowe ER, Mimmack ML, Barbosa AD, Haider A, Isaac I, Ouberai MM, Thiam AR, Patel S, Saudek V, Siniossoglou S, Savage DB. Conserved Amphipathic Helices Mediate Lipid Droplet Targeting of Perilipins 1-3. J Biol Chem. 2016 Mar 25;291(13):6664-78. [PMC]
Seipin
Walther TC, Chung J, Farese RV Jr. Lipid Droplet Biogenesis. Annu Rev Cell Dev Biol. 2017 Oct 6;33:491-510. [PMC]